Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma: results of Intergroup O159/Cancer and Leukemia Group B 9480.
about
Chemotherapy for hormone-refractory prostate cancerStructure of severe fever with thrombocytopenia syndrome virus nucleocapsid protein in complex with suramin reveals therapeutic potential.Small-molecule inhibitors of the interaction between TNF and TNFR.Determination of cutpoints for low and high number of symptoms in patients with advanced cancer.Measurement of affective and activity pain interference using the Brief Pain Inventory (BPI): Cancer and Leukemia Group B 70903.Physiology and endocrinology of hot flashes in prostate cancer.Quality of life associated with treatment of castration-resistant prostate cancer: a review of the literature.Assessment of anticancer-treatment outcome in patients with metastatic castration-resistant prostate cancer-going beyond PSA and imaging, a systematic literature review.Crystal structure of 2-nitro-N-(2-nitro-phen-yl)benzamide.Purinergic signaling triggers endfoot high-amplitude Ca2+ signals and causes inversion of neurovascular coupling after subarachnoid hemorrhage.Crystal structure of 2-(4-chloro-benzamido)-benzoic acid.Pain questionnaire performance in advanced prostate cancer: comparative results from two international clinical trials.
P2860
Q24243797-5F0E2C52-AB2B-4BF2-855C-949BA383A72DQ27677314-79B57270-AD85-4A4D-9CBC-D7D5824C521DQ34519187-64100871-E6F4-4EDA-A794-47BD42E749C0Q36172955-931AEA6F-E9DD-4F56-B92F-42F58EA468B2Q37230455-A4944071-BDE6-40BF-A301-972C2D888E4EQ37502280-924A0FAB-CEAE-4FD2-9891-37E4975D3003Q37974971-CAE28D8B-20CC-4056-BAA6-9FA3D46B426BQ38555581-09E2F226-C61D-45F1-BDF6-0EB219E45292Q42589611-6106C3E9-C41A-4E7C-B8AC-867F461C5272Q42732182-89428799-4FC2-47F3-B09D-A9AAC1FBB92DQ43175763-2DD62C58-0DF2-4776-A77A-275C9E68845FQ48260186-6C4EC84E-91DF-4692-A6C4-EAD458C973BC
P2860
Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma: results of Intergroup O159/Cancer and Leukemia Group B 9480.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Quality of life impact of thre ...... cer and Leukemia Group B 9480.
@ast
Quality of life impact of thre ...... cer and Leukemia Group B 9480.
@en
Quality of life impact of thre ...... cer and Leukemia Group B 9480.
@nl
type
label
Quality of life impact of thre ...... cer and Leukemia Group B 9480.
@ast
Quality of life impact of thre ...... cer and Leukemia Group B 9480.
@en
Quality of life impact of thre ...... cer and Leukemia Group B 9480.
@nl
prefLabel
Quality of life impact of thre ...... cer and Leukemia Group B 9480.
@ast
Quality of life impact of thre ...... cer and Leukemia Group B 9480.
@en
Quality of life impact of thre ...... cer and Leukemia Group B 9480.
@nl
P2093
P50
P356
P1433
P1476
Quality of life impact of thre ...... cer and Leukemia Group B 9480.
@en
P2093
Alice B Kornblith
Daniel Petrylak
David Palchak
Eric J Small
James E Herndon
M Ernest Marshall
Nicholas J Vogelzang
Tim A Ahles
Walter Stadler
P304
P356
10.1002/CNCR.20655
P407
P577
2004-11-01T00:00:00Z